VirnetX Holding Corporation — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024. Financial statement amounts below are in U.S. dollars; amounts are shown in millions unless otherwise noted. The interim financial statements are unaudited.
Business context
VirnetX develops and seeks to commercialize patented cybersecurity and secure communications technology, including its VirnetX One, War Room and VirnetX Matrix products. It also pursues patent licensing and royalty revenue. The company reported only $2,000 of revenue in the quarter, so results remain driven largely by expenses and investment income rather than product or licensing sales.
Financial performance and liquidity
| Metric | Q1 2024 | Q1 2023 or comparison |
|---|---|---|
| Revenue | $0.002 million | $0.002 million |
| Research and development expense | $1.268 million | $1.368 million |
| Selling, general and administrative expense | $3.660 million | $4.548 million |
| Operating loss | $4.926 million | $5.914 million |
| Interest and other income, net | $0.635 million | $1.369 million |
| Net loss | $4.291 million | $4.467 million |
| Basic and diluted loss per share | $1.19 | $1.25 |
| Operating cash used | $3.516 million | $2.711 million |
Revenue was unchanged year over year. R&D expense fell $0.100 million, primarily due to lower engineering costs; SG&A fell $0.888 million, primarily due to lower legal fees and outside services. The smaller net loss was partly offset by lower interest and other income and the absence of the prior-year $0.078 million tax benefit. No meaningful revenue-based margin is apparent given the minimal revenue.
At March 31, cash and cash equivalents were $27.593 million and available-for-sale investments were $22.412 million, totaling $50.005 million. At December 31, 2023, those balances totaled $53.547 million. Working capital was $43.343 million, compared with $52.577 million at December 31. Total assets were $62.275 million and total liabilities were $10.091 million. The filing reports no conventional borrowings or off-balance-sheet arrangements; lease liabilities are a significant contractual obligation.
Operating activities used $3.516 million of cash. Investing activities provided $4.823 million net, largely reflecting investment maturities and sales exceeding purchases; financing activities used $0.003 million. Cash increased by $1.304 million during the quarter.
Material changes and unusual items
- Current liabilities increased to $7.029 million from $1.254 million at year-end, primarily alongside the California facility lease renewal. The company reported a $5.551 million liability for that lease at quarter-end.
- Total scheduled payments for the disclosed leases were $10.626 million before $1.353 million of imputed interest, for reported lease liabilities of $9.273 million. The California lease renewal runs from 2025 through 2035 and carries an approximate $7.5 million commitment under the annual-payment option.
- VirnetX incurred $0.372 million in aircraft fees and reimbursements from an entity managed by its CEO and Chief Administrative Officer, versus $0.287 million in Q1 2023. The agreement is cancellable on 30 days’ notice.
- The company granted 71,000 restricted shares during the quarter and recorded $0.488 million of stock-based compensation. Shares outstanding were 3,680,661 as of May 7, 2024.
- No dividend was declared for Q1 2024. The $20-per-share dividend discussed in the filing was declared in March 2023 and paid in April 2023.
Outlook, risks and contingencies
Management said available cash, cash equivalents and short-term investments are expected to fund the current level of operating expenses, including legal expenses, and related working capital for the foreseeable future. It provided no quantified revenue, earnings or cash-flow guidance. Longer-term revenue expectations rely on licensing and royalties, product commercialization, and partners integrating and reselling VirnetX products. Management cautions that commercialization may not produce significant revenue.
Key disclosed risks include minimal current revenue, long and unpredictable sales cycles, limited technical resources and early-stage commercialization, competition from larger security providers, dependence on successful partner relationships, cybersecurity and product risks, and uncertainty around protecting and monetizing patents. The company also identifies potential capital-raising needs, stock-price volatility and risks associated with export controls and privacy regulation.
Litigation remains a material business uncertainty. The Supreme Court denied VirnetX’s petitions in the Apple II and Mangrove patent matters on February 20, 2024; both cases are reported closed. Several patent challenges resulted in affirmed invalidity findings. Two additional appeals were dismissed in April 2024, after quarter-end. The filing reports no other pending legal proceedings and no threatened or contemplated proceedings known to the company. Management reported effective disclosure controls and no material change in internal control over financial reporting.
Key facts for investors to verify
- Whether product sales, licensing or partner channels begin generating material revenue, given Q1 revenue of just $2,000.
- Cash burn and investment balances over future quarters, and the basis for management’s “foreseeable future” liquidity assessment.
- The timing, payment structure and total cost of the California lease renewal, and the effect of lease obligations on liquidity.
- Developments in remaining patent matters and the commercial impact of adverse litigation and patent-validity outcomes.
- Terms and oversight of the related-party aircraft arrangement and other related-party transactions.